New drug combo aims to shrink Hard-to-Treat cancers
NCT ID NCT07262619
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study tests a new drug called EIK1005, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the combination can shrink tumors. About 160 adults with certain cancer types (like MSI-H or dMMR tumors) will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Calvary Mater Newcastle Hospital
RECRUITINGWaratah, New South Wales, Australia
-
Chris O'Brien Lifehouse (Sydney Cancer Centre)
RECRUITINGCamperdown, Victoria, Australia
-
GenesisCare North Shore (Oncology)
NOT_YET_RECRUITINGSaint Leonards, New South Wales, Australia
-
Grampians Health
RECRUITINGBallarat, Victoria, Australia
-
Health New Zealand
RECRUITINGWellington, New Zealand
-
Memorial Sloan Kettering Cancer Center (MSKCC)
NOT_YET_RECRUITINGNew York, New York, 10022, United States
-
Morristown Medical Center
NOT_YET_RECRUITINGMorristown, New Jersey, 07960, United States
-
Oncology Clinics Victoria (OCV) - Cabrini Brighton Hospital
NOT_YET_RECRUITINGFrankston, Victoria, 3199, Australia
-
Peninsula and Southeast Oncology (PASO) Medical
RECRUITINGFrankston, Victoria, Australia
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.